Accenture stock slides nearly 3% as software sector slumps to start 2026
2 January 2026
1 min read

Accenture stock slides nearly 3% as software sector slumps to start 2026

NEW YORK, January 2, 2026, 4:02 PM ET — After-hours

  • Accenture shares were down about 2.9% in late trade, underperforming a mixed broader market.
  • Software names lagged, with IGV down about 2.8% and Salesforce and ServiceNow off around 4% and 3.8%.
  • Investors are watching next week’s U.S. jobs report and inflation data for rate-cut clues, plus Accenture’s next earnings update in March.

Accenture plc shares were down 2.9% at $260.55 in late trade on Friday, after ranging between $258.07 and $271.92 in the session. The iShares Expanded Tech-Software Sector ETF fell about 2.8%.

The slide matters because markets are shifting out of holiday-thinned trading and into January catalysts that can reset expectations for growth, corporate spending and interest rates.

Accenture is closely watched as a barometer for corporate technology budgets because it sells consulting and outsourcing services across industries. That makes the stock sensitive to shifts in risk appetite around software and IT spending.

Weakness was broad across enterprise software. Salesforce fell about 4.1% and ServiceNow lost 3.8%, while IT services peers IBM and Cognizant were down 1.6% and 1.8%; Infosys rose 2.2%.

The broader tape was steadier. The S&P 500-tracking SPY was up about 0.04% and the Dow-linked DIA gained 0.46%, while the Nasdaq-tracking QQQ slipped 0.18%.

Strategists have warned that valuation will matter more after a strong multi-year run. “Stocks trade expensive on 18 of 20 measures,” said Savita Subramanian, Bank of America’s equity and quant strategist, in a note.

Accenture’s most recent company update came in mid-December, when it beat quarterly revenue estimates but forecast second-quarter revenue of $17.35 billion to $18 billion, Reuters reported. The company also posted adjusted earnings per share of $3.94. 1

Investors have a shareholder calendar ahead as well. Accenture’s annual general meeting is scheduled for Jan. 28 in Dublin, a filing showed.

The next major operational checkpoint is the company’s fiscal second-quarter earnings conference call, scheduled for March 19, according to Accenture’s investor events calendar.

Markets focus is also turning to next week’s U.S. economic data, including the employment report due Jan. 9 and the consumer price index report on Jan. 13. Big banks including JPMorgan are scheduled to kick off earnings season on Jan. 13, Reuters reported.

Traders will watch whether software sentiment stabilizes after Friday’s slide, with Accenture now trading closer to the lower end of its 52-week range of $229.40 to $398.35, according to Yahoo Finance. 2

Stock Market Today

Home Depot stock price: jobs, inflation and a Feb. 24 earnings test loom

Home Depot stock price: jobs, inflation and a Feb. 24 earnings test loom

7 February 2026
Home Depot shares rose 0.7% to $385.15 Friday, trading between $379.10 and $386.37. Investors await a delayed U.S. jobs report Wednesday and CPI data Friday, both postponed by a brief government shutdown. Home Depot reports fourth-quarter earnings Feb. 24. The Dow closed above 50,000 for the first time.
JPMorgan stock price jumps 4% into weekend as Wall Street braces for a busy data week

JPMorgan stock price jumps 4% into weekend as Wall Street braces for a busy data week

7 February 2026
JPMorgan shares rose 3.95% to $322.40 Friday, outpacing other major banks as U.S. stocks rallied and the Dow closed above 50,000 for the first time. The bank recently completed a $3 billion subordinated notes offering. Investors are watching for delayed U.S. jobs data and inflation figures next week, ahead of JPMorgan’s Feb. 23 company update.
AbbVie stock price: ABBV ends week near $223 after earnings swing — what to watch next

AbbVie stock price: ABBV ends week near $223 after earnings swing — what to watch next

7 February 2026
AbbVie shares rose 2% to $223.43 Friday, capping a volatile week marked by earnings and drug sales scrutiny. Moody’s upgraded AbbVie’s credit rating to A2, citing strong performance in immunology and neuroscience. Investors remain focused on Skyrizi and Rinvoq growth amid rising competition and recent regulatory filings. Trading volume stayed below average, with the stock still 9% off its 52-week high.
SK hynix stock price slips into Monday after S&P upgrade, tech selloff

SK hynix stock price slips into Monday after S&P upgrade, tech selloff

7 February 2026
SK hynix shares closed at 839,000 won, down 0.36% Friday and 8% for the week, as tech stocks retreated across Asia. S&P Global Ratings upgraded the chipmaker to “BBB+” with a positive outlook, citing strong HBM sales. The KOSPI fell 1.4% Friday, ending a six-week winning streak. Traders await Monday’s Seoul open for signs of further tech weakness.
Sidus Space (SIDU) stock surges 34% after new 7.4% stake filing hits SEC
Previous Story

Sidus Space (SIDU) stock surges 34% after new 7.4% stake filing hits SEC

Microsoft stock drops more than 2% to start 2026 as investors trim megacap tech exposure (MSFT)
Next Story

Microsoft stock drops more than 2% to start 2026 as investors trim megacap tech exposure (MSFT)

Go toTop